Sastry, N. G., Wan, X., Huang, T., Alvarez, A. A., Pangeni, R. P., Song, X., . . . Cheng, S. (2020). LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement. Neuro Oncol.
Chicago Style CitationSastry, Namratha G., et al. "LY6K Promotes Glioblastoma Tumorigenicity Via CAV-1–mediated ERK1/2 Signaling Enhancement." Neuro Oncol 2020.
MLA CitationSastry, Namratha G., et al. "LY6K Promotes Glioblastoma Tumorigenicity Via CAV-1–mediated ERK1/2 Signaling Enhancement." Neuro Oncol 2020.
Warning: These citations may not always be 100% accurate.